Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Stroke

  Free Subscription


Articles published in Am J Cardiol

Retrieve available abstracts of 139 articles:
HTML format
Text format



Single Articles


    May 2019
  1. PATTI G, Sticchi A, Bisignani A, Pelliccia F, et al
    Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment.
    Am J Cardiol. 2019 May 25. pii: S0002-9149(19)30580.
    PubMed     Text format     Abstract available


    April 2019
  2. SHIBUYA J, Kobayashi N, Asai K, Tsurumi M, et al
    Comparison of Coronary Culprit Lesion Morphology Determined by Optical Coherence Tomography and Relation to Outcomes in Patients Diagnosed with Acute Coronary Syndrome During Winter -vs- Other Seasons.
    Am J Cardiol. 2019 Apr 8. pii: S0002-9149(19)30410.
    PubMed     Text format     Abstract available


    January 2019
  3. NAZIR S, Elgin E, Loynd R, Zaman M, et al
    ST-Elevation Myocardial Infarction Associated With Infective Endocarditis.
    Am J Cardiol. 2019 Jan 31. pii: S0002-9149(19)30125.
    PubMed     Text format     Abstract available


  4. ZABCZYK M, Meus R, Malinowski KP, Natorska J, et al
    A Prothrombotic State in Patients With a History of Left Ventricular Thrombus.
    Am J Cardiol. 2019 Jan 24. pii: S0002-9149(19)30099.
    PubMed     Text format     Abstract available


  5. BANGALORE S, Schwamm LH, Smith EE, Hellkamp AS, et al
    Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack.
    Am J Cardiol. 2019 Jan 11. pii: S0002-9149(19)30040.
    PubMed     Text format     Abstract available


    September 2018
  6. KORJIAN S, Braunwald E, Daaboul Y, Mi M, et al
    Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial).
    Am J Cardiol. 2018 Sep 7. pii: S0002-9149(18)31733.
    PubMed     Text format     Abstract available


    May 2018
  7. YESIN M, Karakoyun S, Kalcik M, Gursoy MO, et al
    Status of the Epicardial Coronary Arteries in Non-ST Elevation Acute Coronary Syndrome in Patients with Mechanical Prosthetic Heart Valves (from the TROIA-ACS Trial).
    Am J Cardiol. 2018 May 11. pii: S0002-9149(18)31046.
    PubMed     Text format     Abstract available


  8. GOKSULUK H, Gulec S, Ozyuncu N, Kurklu ST, et al
    Comparison of Frequency of Silent Cerebral Infarction After Coronary Angiography and Stenting With Transradial Versus Transfemoral Approaches.
    Am J Cardiol. 2018 May 11. pii: S0002-9149(18)31057.
    PubMed     Text format     Abstract available


  9. INOUE YY, Ipek EG, Khurram IM, Ciuffo L, et al
    Relation of Electrocardiographic Left Atrial Abnormalities to Risk of Stroke in Patients with Atrial Fibrillation.
    Am J Cardiol. 2018 May 3. pii: S0002-9149(18)30863.
    PubMed     Text format     Abstract available


    April 2018
  10. NEUPANE S, Singh H, Lammer J, Othman H, et al
    Meta-Analysis of Transcatheter Valve-in-Valve Implantation Versus Redo Aortic Valve Surgery for Bioprosthetic Aortic Valve Dysfunction.
    Am J Cardiol. 2018 Apr 19. pii: S0002-9149(18)30290.
    PubMed     Text format     Abstract available


  11. SORIGUE M, Sarrate E, Franch-Sarto M, Sancho JM, et al
    Risk of Cardioembolic Stroke in Patients With Cancer and Atrial Fibrillation.
    Am J Cardiol. 2018 Apr 18. pii: S0002-9149(18)30296.
    PubMed     Text format    


    March 2018
  12. WETTERSTEN N, Cushman M, Howard VJ, Hartmann O, et al
    Usefulness of Proneurotensin to Predict Cardiovascular and All-Cause Mortality in a United States Population (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2018 Mar 28. pii: S0002-9149(18)30377.
    PubMed     Text format     Abstract available


  13. HERNANDEZ I, Zhang Y, Saba S
    Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients With Atrial Fibrillation.
    Am J Cardiol. 2018 Mar 28. pii: S0002-9149(18)30380.
    PubMed     Text format     Abstract available


  14. SLIVNICK JA, Yeow RY, McMahon C, Paje DG, et al
    Current Trends in Anticoagulation Bridging for Patients With Chronic Atrial Fibrillation on Warfarin Undergoing Endoscopy.
    Am J Cardiol. 2018 Mar 16. pii: S0002-9149(18)30279.
    PubMed     Text format     Abstract available


  15. VENDRIK J, van Mourik MS, van Kesteren F, Henstra MJ, et al
    Comparison of Outcomes of Transfemoral Aortic Valve Implantation in Patients <90 With Those >90 Years of Age.
    Am J Cardiol. 2018 Mar 15. pii: S0002-9149(18)30292.
    PubMed     Text format     Abstract available


  16. LEE OH, Kim JS, Pak HN, Hong GR, et al
    Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation.
    Am J Cardiol. 2018 Mar 14. pii: S0002-9149(18)30281.
    PubMed     Text format     Abstract available


  17. ABUBAKAR H, Yassin AS, Akintoye E, Bakhit K, et al
    Financial Implications and Impact of Pre-existing Atrial Fibrillation on In-Hospital Outcomes in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the National Inpatient Database).
    Am J Cardiol. 2018 Mar 14. pii: S0002-9149(18)30288.
    PubMed     Text format     Abstract available


  18. SRIVASTAVA P, Butler J, Shroyer AL, Lacey M, et al
    Impact of Depressive Disorder on Access and Quality of Care in Veterans With Prevalent Cardiovascular Disease.
    Am J Cardiol. 2018 Mar 14. pii: S0002-9149(18)30284.
    PubMed     Text format     Abstract available


  19. DUDEK D, Ebner A, Sobczynski R, Trebacz J, et al
    Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial).
    Am J Cardiol. 2018 Mar 13. pii: S0002-9149(18)30282.
    PubMed     Text format     Abstract available


  20. NAGANUMA T, Tsujita K, Mitomo S, Ishiguro H, et al
    Impact of Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions (from the Japanese Multicenter Registry).
    Am J Cardiol. 2018 Mar 13. pii: S0002-9149(18)30268.
    PubMed     Text format     Abstract available


  21. KIM H, Kim IC, Yoon HJ, Park HS, et al
    Prognostic Usefulness of Tricuspid Annular Diameter for Cardiovascular Events in Patients With Tricuspid Regurgitation of Moderate to Severe Degree.
    Am J Cardiol. 2018 Mar 2. pii: S0002-9149(18)30249.
    PubMed     Text format     Abstract available


  22. ITO S, Watanabe H, Morimoto T, Yoshikawa Y, et al
    Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention.
    Am J Cardiol. 2018 Mar 1. pii: S0002-9149(18)30245.
    PubMed     Text format     Abstract available


  23. ROGERS T, Waksman R, Harrison JK, Deeb GM, et al
    Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis.
    Am J Cardiol. 2018 Mar 1. pii: S0002-9149(18)30243.
    PubMed     Text format     Abstract available


    February 2018
  24. KHAN SU, Khan MU, Ghani AR, Lone AN, et al
    Meta-Analysis of Antithrombotic Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention.
    Am J Cardiol. 2018 Feb 14. pii: S0002-9149(18)30178.
    PubMed     Text format     Abstract available


  25. MANSOUR M, Heist EK, Agarwal R, Bunch TJ, et al
    Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation.
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30187.
    PubMed     Text format     Abstract available


  26. CHEN YR, Hsieh FI, Chang CC, Chi NF, et al
    Effect on Risk of Stroke and Acute Myocardial Infarction of Nonselective Nonsteroidal Anti-Inflammatory Drugs in Patients With Rheumatoid Arthritis.
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30189.
    PubMed     Text format     Abstract available


  27. JAAKKOLA S, Kiviniemi TO, Nuotio I, Hartikainen J, et al
    Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study).
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30180.
    PubMed     Text format     Abstract available


  28. FRIKHA Z, Ferreira JP, Bozec E, McMurray JJV, et al
    Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative).
    Am J Cardiol. 2018 Feb 5. pii: S0002-9149(18)30154.
    PubMed     Text format     Abstract available


  29. MEDINA-INOJOSA JR, Batsis JA, Supervia M, Somers VK, et al
    Relation of Waist-Hip Ratio to Long-Term Cardiovascular Events in Patients With Coronary Artery Disease.
    Am J Cardiol. 2018 Feb 2. pii: S0002-9149(18)30090.
    PubMed     Text format     Abstract available


  30. MCCULLOUGH PA, Ballantyne CM, Sanganalmath SK, Langslet G, et al
    Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
    Am J Cardiol. 2018 Feb 2. pii: S0002-9149(18)30093.
    PubMed     Text format     Abstract available


    January 2018
  31. SORIGUE M, Sarrate E, Franch-Sarto M, Santos-Gomez M, et al
    Anticoagulant Agents for Atrial Fibrillation in Cancer Patients.
    Am J Cardiol. 2018 Jan 31. pii: S0002-9149(18)30107.
    PubMed     Text format    


  32. KODUMURI V, Balasubramanian S, Vij A, Siddamsetti S, et al
    A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Disease.
    Am J Cardiol. 2018 Jan 31. pii: S0002-9149(18)30092.
    PubMed     Text format     Abstract available


  33. HUYNH T, Montigny M, Iftikhar U, Gagnon R, et al
    Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study).
    Am J Cardiol. 2018 Jan 31. pii: S0002-9149(18)30059.
    PubMed     Text format     Abstract available


  34. VENDRIK J, van Kesteren F, van Mourik MS, Piek JJ, et al
    Procedural Outcome and Midterm Survival of Lower Risk Transfemoral Transcatheter Aortic Valve Implantation Patients Treated With the SAPIEN XT or SAPIEN 3 Device.
    Am J Cardiol. 2018 Jan 11. pii: S0002-9149(18)30044.
    PubMed     Text format     Abstract available


  35. HIZOH I, Banhegyi G, Domokos D, Gulyas Z, et al
    Impact of Selective Aspiration Thrombectomy on Mortality in Patients With ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2018 Jan 10. pii: S0002-9149(18)30053.
    PubMed     Text format     Abstract available


  36. SINGH SM, Webster L, Qiu F, Austin PC, et al
    Effect of Electrophysiology Assessment on Mortality and Hospitalizations in Patients With New-Onset Atrial Fibrillation.
    Am J Cardiol. 2018 Jan 9. pii: S0002-9149(18)30051.
    PubMed     Text format     Abstract available


  37. HUSSAIN N, Gersh BJ, Gonzalez Carta K, Sydo N, et al
    Impact of Cardiorespiratory Fitness on Frequency of Atrial Fibrillation, Stroke, and All-Cause Mortality.
    Am J Cardiol. 2018;121:41-49.
    PubMed     Text format     Abstract available


  38. STONE J, Mor-Avi V, Ardelt A, Lang RM, et al
    Frequency of Inverted Electrocardiographic T Waves (Cerebral T Waves) in Patients With Acute Strokes and Their Relation to Left Ventricular Wall Motion Abnormalities.
    Am J Cardiol. 2018;121:120-124.
    PubMed     Text format     Abstract available


    December 2017
  39. ELBADAWI A, Elgendy IY, Ha LD, Baig B, et al
    In-Hospital Cerebrovascular Outcomes of Patients With Atrial Fibrillation and Cancer (from the National Inpatient Sample Database).
    Am J Cardiol. 2017 Dec 20. pii: S0002-9149(17)31852.
    PubMed     Text format     Abstract available


  40. BISSON A, Bodin A, Clementy N, Babuty D, et al
    Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort.
    Am J Cardiol. 2017 Dec 2. pii: S0002-9149(17)31774.
    PubMed     Text format     Abstract available


    November 2017
  41. LEE CH, Lee JY, Park GM, Lee SW, et al
    Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DE
    Am J Cardiol. 2017 Nov 24. pii: S0002-9149(17)31763.
    PubMed     Text format     Abstract available


  42. LIP GYH, Merino JL, Dan GA, Themistoclakis S, et al
    Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).
    Am J Cardiol. 2017 Nov 20. pii: S0002-9149(17)31616.
    PubMed     Text format     Abstract available


    October 2017
  43. KUMAR N, Khera R, Garg N, Echouffo-Tcheugui JB, et al
    Comparison of Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Chronic Kidney Disease.
    Am J Cardiol. 2017 Oct 31. pii: S0002-9149(17)31686.
    PubMed     Text format     Abstract available


  44. ORVIN K, Levi A, Landes U, Bental T, et al
    Usefulness of the CHA2DS2-VASc Score to Predict Outcome in Patients Who Underwent Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2017 Oct 19. pii: S0002-9149(17)31620.
    PubMed     Text format     Abstract available


  45. GARG PK, O'Neal WT, Ogunsua A, Thacker EL, et al
    Usefulness of the American Heart Association's Life Simple 7 to Predict the Risk of Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke [REGARDS] Study).
    Am J Cardiol. 2017 Oct 19. pii: S0002-9149(17)31615.
    PubMed     Text format     Abstract available


  46. NISHIMURA M, Hsu JC
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    Am J Cardiol. 2017 Oct 12. pii: S0002-9149(17)31602.
    PubMed     Text format     Abstract available


  47. JAKOBSEN L, Terkelsen CJ, Sondergaard L, Backer OD, et al
    Short- and Long-Term Mortality and Stroke Risk After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2017 Oct 10. pii: S0002-9149(17)31586.
    PubMed     Text format     Abstract available


    September 2017
  48. PATELL R, Gutierrez A, Rybicki L, Khorana AA, et al
    Usefulness of CHADS2 and CHA2DS2-VASc Scores for Stroke Prediction in Patients With Cancer and Atrial Fibrillation.
    Am J Cardiol. 2017 Sep 20. pii: S0002-9149(17)31457.
    PubMed     Text format     Abstract available


    August 2017
  49. WANDELL P, Carlsson AC, Holzmann MJ, Arnlov J, et al
    Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31383.
    PubMed     Text format     Abstract available


  50. DURHAM TA, Hassmiller Lich K, Viera AJ, Fine JP, et al
    Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 12. pii: S0002-9149(17)31297.
    PubMed     Text format     Abstract available


  51. KOSMIDOU I, Embacher M, McAndrew T, Dizon JM, et al
    Early Ventricular Tachycardia or Fibrillation in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention and Impact on Mortality and Stent Thrombosis (from the Harmonizing Outcomes with Revascularization
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31286.
    PubMed     Text format     Abstract available


  52. ELGENDY AY, Mahtta D, Barakat AF, Abuzaid A, et al
    Meta-Analysis of Safety and Efficacy of Uninterrupted Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists for Catheter Ablation of Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31302.
    PubMed     Text format     Abstract available


  53. HERNANDEZ I, Zhang Y, Saba S
    Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31298.
    PubMed     Text format     Abstract available


  54. CHEN ST, Hellkamp AS, Becker RC, Berkowitz SD, et al
    Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in
    Am J Cardiol. 2017 Aug 7. pii: S0002-9149(17)31301.
    PubMed     Text format     Abstract available


  55. BAI Y, Shi XB, Ma CS, Lip GYH, et al
    Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban.
    Am J Cardiol. 2017 Aug 1. pii: S0002-9149(17)31245.
    PubMed     Text format     Abstract available


    July 2017
  56. SHANTHA GPS, Mentias A, Bhise V, Kumar A, et al
    Gender Differences in the Trends of Hospitalizations for Acute Stroke Among Patients With Atrial Fibrillation in the United States: 2005 to 2014.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31217.
    PubMed     Text format     Abstract available


  57. LIU T, Hui J, Hou YY, Zou Y, et al
    Meta-Analysis of Efficacy and Safety of Low-Intensity Warfarin Therapy for East Asian Patients With Nonvalvular Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31223.
    PubMed     Text format     Abstract available


  58. YAO X, Gersh BJ, Sangaralingham LR, Kent DM, et al
    Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31224.
    PubMed     Text format     Abstract available


  59. CARROLL BJ, Pemberton H, Bauer KA, Chu LM, et al
    Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism.
    Am J Cardiol. 2017 Jul 26. pii: S0002-9149(17)31198.
    PubMed     Text format     Abstract available


  60. KHURSHID S, Weng LC, Hulme OL, Ellinor PT, et al
    Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 24. pii: S0002-9149(17)31181.
    PubMed     Text format     Abstract available


  61. WIESEL J, Salomone TJ
    Screening for Atrial Fibrillation in Patients >/=65 Years Using an Automatic Blood Pressure Monitor in a Skilled Nursing Facility.
    Am J Cardiol. 2017 Jul 24. pii: S0002-9149(17)31180.
    PubMed     Text format     Abstract available


  62. SOLIMAN EZ, Zhang ZM, Judd S, Howard VJ, et al
    Comparison of Risk of Atrial Fibrillation Among Employed Versus Unemployed (from the REasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2017 Jul 21. pii: S0002-9149(17)31165.
    PubMed     Text format     Abstract available


  63. LOIKAS D, Forslund T, Wettermark B, Schenck-Gustafsson K, et al
    Sex and Gender Differences in Thromboprophylactic Treatment of Patients With Atrial Fibrillation After the Introduction of Non-Vitamin K Oral Anticoagulants.
    Am J Cardiol. 2017 Jul 21. pii: S0002-9149(17)31166.
    PubMed     Text format     Abstract available


  64. ADMASSIE E, Chalmers L, Bereznicki LR
    Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31117.
    PubMed     Text format     Abstract available


  65. HONG C, Alluri K, Shariff N, Khattak F, et al
    Usefulness of the CHA2DS2-VASc Score to Predict Mortality in Defibrillator Recipients.
    Am J Cardiol. 2017;120:83-86.
    PubMed     Text format     Abstract available


    June 2017
  66. LIP GYH, Al-Saady N, Jin J, Sun M, et al
    Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30957.
    PubMed     Text format     Abstract available


  67. ASHBURNER JM, Singer DE, Lubitz SA, Borowsky LH, et al
    Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants.
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30956.
    PubMed     Text format     Abstract available


  68. SILBERBERG A, Tan MK, Yan AT, Angaran P, et al
    Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Netw
    Am J Cardiol. 2017 Jun 1. pii: S0002-9149(17)30863.
    PubMed     Text format     Abstract available


    May 2017
  69. WASHAM JB, Hellkamp AS, Lokhnygina Y, Piccini JP, et al
    Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).
    Am J Cardiol. 2017 May 29. pii: S0002-9149(17)30862.
    PubMed     Text format     Abstract available


  70. LEMPEREUR M, Aminian A, Freixa X, Gafoor S, et al
    Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
    Am J Cardiol. 2017 May 12. pii: S0002-9149(17)30782.
    PubMed     Text format     Abstract available


  71. SHAH RR, Pillai A, Schafer P, Meggo D, et al
    Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation.
    Am J Cardiol. 2017 May 10. pii: S0002-9149(17)30777.
    PubMed     Text format     Abstract available


  72. DE ASMUNDIS C, Mugnai G, Chierchia GB, Sieira J, et al
    Long-Term Follow-Up of Probands With Brugada Syndrome.
    Am J Cardiol. 2017;119:1392-1400.
    PubMed     Text format     Abstract available


  73. LEE MS, Park KW, Shlofmitz E, Shlofmitz RA, et al
    Comparison of Rotational Atherectomy Versus Orbital Atherectomy for the Treatment of Heavily Calcified Coronary Plaques.
    Am J Cardiol. 2017;119:1320-1323.
    PubMed     Text format     Abstract available


    April 2017
  74. LAUBE ES, Yu A, Gupta D, Miao Y, et al
    Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30697.
    PubMed     Text format     Abstract available


  75. MUGNAI G, de Asmundis C, Iacopino S, Stroker E, et al
    Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30700.
    PubMed     Text format     Abstract available


  76. DE HARO J, Michel I, Bleda S, Canibano C, et al
    Carotid Stenting in Patients With High Risk Versus Standard Risk for Open Carotid Endarterectomy (REAL-1 Trial).
    Am J Cardiol. 2017 Apr 26. pii: S0002-9149(17)30711.
    PubMed     Text format     Abstract available


  77. GOLIVE A, May HT, Bair TL, Jacobs V, et al
    The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30627.
    PubMed     Text format     Abstract available


    March 2017
  78. AGARWAL S, Sud K, Thakkar B, Menon V, et al
    Changing Trends of Atherosclerotic Risk Factors Among Patients With Acute Myocardial Infarction and Acute Ischemic Stroke.
    Am J Cardiol. 2017 Mar 31. pii: S0002-9149(17)30213.
    PubMed     Text format     Abstract available


  79. VELASQUEZ-RODRIGUEZ J, Diez-Delhoyo F, Valero-Masa MJ, Vicent L, et al
    Prognostic Impact of Age and Hemoglobin in Acute ST-Segment Elevation Myocardial Infarction Treated With Reperfusion Therapy.
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30341.
    PubMed     Text format     Abstract available


  80. BALLA SR, Cyr DD, Lokhnygina Y, Becker RC, et al
    Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30352.
    PubMed     Text format     Abstract available


  81. NGUYEN P, Kamran H, Nasir S, Chan W, et al
    Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine.
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30358.
    PubMed     Text format     Abstract available


  82. ELBADAWI A, Olorunfemi O, Ogunbayo GO, Saad M, et al
    Cardiovascular Outcomes With Surgical Left Atrial Appendage Exclusion in Patients With Atrial Fibrillation Who Underwent Valvular Heart Surgery (from the National Inpatient Sample Database).
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30361.
    PubMed     Text format     Abstract available


  83. STEINBERG BA, Simon DN, Thomas L, Ansell J, et al
    Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fib
    Am J Cardiol. 2017 Mar 28. pii: S0002-9149(17)30201.
    PubMed     Text format     Abstract available


  84. CHERIAN TS, Shrader P, Fonarow GC, Allen LA, et al
    Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30289.
    PubMed     Text format     Abstract available


  85. O'NEAL WT, Sandesara P, Hammadah M, Venkatesh S, et al
    Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30282.
    PubMed     Text format     Abstract available


  86. BOSE A, O'Neal WT, Bennett A, Judd SE, et al
    Relation Between Estimated Cardiorespiratory Fitness and Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30285.
    PubMed     Text format     Abstract available


    February 2017
  87. XIE JX, Glorioso TJ, Dattilo PB, Aggarwal V, et al
    Effect of Chronic Kidney Disease on Mortality in Patients Who Underwent Lower Extremity Peripheral Vascular Intervention.
    Am J Cardiol. 2017;119:669-674.
    PubMed     Text format     Abstract available


  88. BYKOV K, Schneeweiss S, Donneyong MM, Dong YH, et al
    Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors.
    Am J Cardiol. 2017;119:651-657.
    PubMed     Text format     Abstract available


  89. QIAN C, Feng H, Cao J, Wei B, et al
    Meta-Analysis of Randomized Control Trials Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Significant Left Main Coronary Narrowing.
    Am J Cardiol. 2017 Feb 10. pii: S0002-9149(17)30126.
    PubMed     Text format     Abstract available


  90. DIDIER R, Gaglia MA Jr, Lipinski MJ, Koifman E, et al
    Comparison of Baseline Characteristics and Inhospital Outcomes of Patients and Use of Bare Metal Versus Drug-Eluting Stents During Percutaneous Coronary Intervention 2005 to 2015 at a Single Tertiary Hospital.
    Am J Cardiol. 2017 Feb 9. pii: S0002-9149(17)30115.
    PubMed     Text format     Abstract available


    January 2017
  91. POLI D, Antonucci E, Pengo V, Testa S, et al
    Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jan 26. pii: S0002-9149(16)32003.
    PubMed     Text format     Abstract available


  92. ABE M, Ogawa H, Ishii M, Masunaga N, et al
    Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry).
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30054.
    PubMed     Text format     Abstract available


  93. COHEN R, Bavishi C, Haider S, Thankachen J, et al
    Meta-Analysis of Relation of Vital Exhaustion to Cardiovascular Disease Events.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30067.
    PubMed     Text format     Abstract available


  94. QI Z, Chen H, Wen Z, Yuan F, et al
    Relation of Low-Density Lipoprotein Cholesterol to Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30055.
    PubMed     Text format     Abstract available


  95. SHERAZI S, Kutyifa V, McNitt S, Papernov A, et al
    Effect of Gender on the Risk of Neurologic Events and Subsequent Outcomes in Patients With Left Ventricular Assist Devices.
    Am J Cardiol. 2017;119:297-301.
    PubMed     Text format     Abstract available


  96. MUSCARI A, Bonfiglioli A, Faccioli L, Ghinelli M, et al
    Usefulness of the MrWALLETS Scoring System to Predict First Diagnosed Atrial Fibrillation in Patients With Ischemic Stroke.
    Am J Cardiol. 2017 Jan 5. pii: S0002-9149(16)32005.
    PubMed     Text format     Abstract available


    December 2016
  97. NORTON L, Tsiperfal A, Cook K, Bagdasarian A, et al
    Effectiveness and Safety of an Independently Run Nurse Practitioner Outpatient Cardioversion Program (2009 to 2014).
    Am J Cardiol. 2016;118:1842-1846.
    PubMed     Text format     Abstract available


  98. FREIXA X, Llull L, Gafoor S, Cruz-Gonzalez I, et al
    Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion.
    Am J Cardiol. 2016;118:1836-1841.
    PubMed     Text format     Abstract available


  99. JONES PH, Bays HE, Chaudhari U, Pordy R, et al
    Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials.
    Am J Cardiol. 2016;118:1805-1811.
    PubMed     Text format     Abstract available


  100. PEACOCK WF, Tamayo S, Sicignano N, Hopf KP, et al
    Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus.
    Am J Cardiol. 2016 Dec 9. pii: S0002-9149(16)31892.
    PubMed     Text format     Abstract available


  101. BRASCIA D, Reichart D, Onorati F, Perrotti A, et al
    Validation of Bleeding Classifications in Coronary Artery Bypass Grafting.
    Am J Cardiol. 2016 Dec 3. pii: S0002-9149(16)31896.
    PubMed     Text format     Abstract available


  102. LIP GY, Waldo AL, Ip J, Martin DT, et al
    Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
    Am J Cardiol. 2016;118:1680-1684.
    PubMed     Text format     Abstract available


    November 2016
  103. GUO L, Li S, Wang P, Zhong X, et al
    Comparative Efficacy of Clinical Events Prevention of Five Anticoagulants in Patients With Atrial Fibrillation (A Network Meta-Analysis).
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31817.
    PubMed     Text format     Abstract available


  104. SUN Y, Liu X, He Y, Tang M, et al
    Meta-Analysis of Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31824.
    PubMed     Text format     Abstract available


  105. BANGALORE S, Fayyad R, Messerli FH, Laskey R, et al
    Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
    Am J Cardiol. 2016 Nov 4. pii: S0002-9149(16)31749.
    PubMed     Text format     Abstract available


  106. KARUNANITHI Z, Nyboe C, Hjortdal VE
    Long-Term Risk of Atrial Fibrillation and Stroke in Patients With Atrial Septal Defect Diagnosed in Childhood.
    Am J Cardiol. 2016 Nov 1. pii: S0002-9149(16)31726.
    PubMed     Text format     Abstract available


  107. GARG L, Agrawal S, Pew T, Hanzel GS, et al
    Psoas Muscle Area as a Predictor of Outcomes in Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Nov 1. pii: S0002-9149(16)31730.
    PubMed     Text format     Abstract available


    October 2016
  108. OHYA M, Kadota K, Toyofuku M, Morimoto T, et al
    Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).
    Am J Cardiol. 2016 Oct 31. pii: S0002-9149(16)31744.
    PubMed     Text format     Abstract available


  109. BENJAMIN MM, Chaddha A, Sampene E, Field ME, et al
    Comparison of Outcomes of Atrial Fibrillation in Patients With Reduced Versus Preserved Left Ventricular Ejection Fraction.
    Am J Cardiol. 2016 Oct 11. pii: S0002-9149(16)31489.
    PubMed     Text format     Abstract available


  110. MARTIN RC, Burgin WS, Schabath MB, Kirby B, et al
    Gender-Specific Differences for Risk of Disability and Death in Atrial Fibrillation-Related Stroke.
    Am J Cardiol. 2016 Oct 8. pii: S0002-9149(16)31621.
    PubMed     Text format     Abstract available


  111. HELLYER JA, Azarbal F, Than CT, Fan J, et al
    Impact of Baseline Stroke Risk and Bleeding Risk on Warfarin International Normalized Ratio Control in Atrial Fibrillation (from the TREAT-AF Study).
    Am J Cardiol. 2016 Oct 8. pii: S0002-9149(16)31617.
    PubMed     Text format     Abstract available


  112. MOREYRA AE, Maniatis GA, Gu H, Swerdel JN, et al
    Frequency of Stroke After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting (from an Eleven-Year Statewide Analysis).
    Am J Cardiol. 2016 Oct 8. pii: S0002-9149(16)31618.
    PubMed     Text format     Abstract available


    September 2016
  113. VARMDAL T, Janszky I, Bakken IJ, Ellekjaer H, et al
    Percutaneous Coronary Intervention as a Trigger for Stroke.
    Am J Cardiol. 2016 Sep 29. pii: S0002-9149(16)31571.
    PubMed     Text format     Abstract available


  114. CODNER P, Levi A, Gargiulo G, Praz F, et al
    Impact of Renal Dysfunction on Results of Transcatheter Aortic Valve Replacement Outcomes in a Large Multicenter Cohort.
    Am J Cardiol. 2016 Sep 15. pii: S0002-9149(16)31498.
    PubMed     Text format     Abstract available


  115. DAWOOD FZ, Judd S, Howard VJ, Limdi NA, et al
    High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2016 Sep 14. pii: S0002-9149(16)31476.
    PubMed     Text format     Abstract available


  116. MAKAM RC, Erskine N, McManus DD, Lessard D, et al
    Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Am J Cardiol. 2016 Sep 13. pii: S0002-9149(16)31472.
    PubMed     Text format     Abstract available


    August 2016
  117. LO JY, Minich LL, Tani LY, Wilkes J, et al
    Factors Associated With Resource Utilization and Coronary Artery Dilation in Refractory Kawasaki Disease (from the Pediatric Health Information System Database).
    Am J Cardiol. 2016 Aug 31. pii: S0002-9149(16)31430.
    PubMed     Text format     Abstract available


  118. THANOPOULOS BV, Ninios V, Dardas P, Giannopoulos A, et al
    Catheter Closure Through a Venous Approach of Patent Ductus Arteriosus in Small Pediatric Patients Using Combined Angiographic and Echocardiographic Guidance.
    Am J Cardiol. 2016 Aug 23. pii: S0002-9149(16)31383.
    PubMed     Text format     Abstract available


  119. TRZECIAK P, Wozakowska-Kaplon B, Niedziela J, Gierlotka M, et al
    Comparison of Inhospital and 12- and 36-Month Outcomes After Acute Coronary Syndrome in Men Versus Women <40 Years (from the PL-ACS Registry).
    Am J Cardiol. 2016 Aug 12. pii: S0002-9149(16)31337.
    PubMed     Text format     Abstract available


  120. KOHLI P, Knowles JW, Sarraju A, Waters DD, et al
    Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials).
    Am J Cardiol. 2016 Aug 12. pii: S0002-9149(16)31324.
    PubMed     Text format     Abstract available


  121. BIAGINI E, Pazzi C, Olivotto I, Musumeci B, et al
    Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2016;118:432-9.
    PubMed     Text format     Abstract available


    July 2016
  122. PATEL NJ, Pau D, Nalluri N, Bhatt P, et al
    Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31234.
    PubMed     Text format     Abstract available


  123. MURALIDHARAN A, Thiagarajan K, Van Ham R, Gleason TG, et al
    Meta-Analysis of Perioperative Stroke and Mortality in Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Jul 18. pii: S0002-9149(16)31181.
    PubMed     Text format     Abstract available


  124. TAKAHASHI H, Jimbo Y, Takano H, Abe H, et al
    Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
    Am J Cardiol. 2016;118:222-5.
    PubMed     Text format     Abstract available


  125. ATHER S, Shendre A, Beasley TM, Brown T, et al
    Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.
    Am J Cardiol. 2016;118:232-6.
    PubMed     Text format     Abstract available


    June 2016
  126. WONG CX, Odutayo A, Emdin CA, Kinnear NJ, et al
    Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis.
    Am J Cardiol. 2016;117:1934-41.
    PubMed     Text format     Abstract available


  127. QUINN GR, Singer DE, Chang Y, Go AS, et al
    How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?
    Am J Cardiol. 2016 Jun 15. pii: S0002-9149(16)31035.
    PubMed     Text format     Abstract available


  128. FAUCHIER L, Lecoq C, Ancedy Y, Stamboul K, et al
    Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting.
    Am J Cardiol. 2016 Jun 14. pii: S0002-9149(16)31039.
    PubMed     Text format     Abstract available


    May 2016
  129. HANSEN GM, Egeberg A, Holmstrup P, Hansen PR, et al
    Relation of Periodontitis to Risk of Cardiovascular and All-Cause Mortality (from a Danish Nationwide Cohort Study).
    Am J Cardiol. 2016 May 30. pii: S0002-9149(16)30939.
    PubMed     Text format     Abstract available


  130. SKELDING KA, Yakubov SJ, Kleiman NS, Reardon MJ, et al
    Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial).
    Am J Cardiol. 2016 May 28. pii: S0002-9149(16)30954.
    PubMed     Text format     Abstract available


  131. EMDIN CA, Odutayo A, Wong CX, Tran J, et al
    Meta-Analysis of Anxiety as a Risk Factor for Cardiovascular Disease.
    Am J Cardiol. 2016 May 28. pii: S0002-9149(16)30944.
    PubMed     Text format     Abstract available


  132. FORREST JK, Adams DH, Popma JJ, Reardon MJ, et al
    Transcatheter Aortic Valve Replacement in Women Versus Men (from the US CoreValve Trials).
    Am J Cardiol. 2016 May 14. pii: S0002-9149(16)30867.
    PubMed     Text format     Abstract available


  133. SWAMINATHAN RV, Feldman DN, Pashun RA, Patil RK, et al
    Gender Differences in In-Hospital Outcomes After Coronary Artery Bypass Grafting.
    Am J Cardiol. 2016 May 14. pii: S0002-9149(16)30858.
    PubMed     Text format     Abstract available


  134. JACOBS V, May HT, Bair TL, Crandall BG, et al
    Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Am J Cardiol. 2016 May 5. pii: S0002-9149(16)30561.
    PubMed     Text format     Abstract available


  135. MOON J, Suh J, Oh PC, Lee K, et al
    Relation of Stature to Outcomes in Korean Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (from the INTERSTELLAR Registry).
    Am J Cardiol. 2016 May 5. pii: S0002-9149(16)30568.
    PubMed     Text format     Abstract available


  136. HECHT EM, Arheart KL, Lee DJ, Hennekens CH, et al
    Interrelation of Cadmium, Smoking, and Cardiovascular Disease (from the National Health and Nutrition Examination Survey).
    Am J Cardiol. 2016 May 4. pii: S0002-9149(16)30560.
    PubMed     Text format     Abstract available


    April 2016
  137. PROIETTI M, Lane DA, Lip GY
    Relation of Nonvalvular Atrial Fibrillation to Body Mass Index (from the SPORTIF Trials).
    Am J Cardiol. 2016 Apr 21. pii: S0002-9149(16)30494.
    PubMed     Text format     Abstract available


  138. GOKSULUK H, Gulec S, Ozcan OU, Gerede M, et al
    Usefulness of Neuron-Specific Enolase to Detect Silent Neuronal Ischemia After Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Apr 6. pii: S0002-9149(16)30424.
    PubMed     Text format     Abstract available


    March 2016
  139. LEIGH JA, O'Neal WT, Soliman EZ
    Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged >/=65 Years.
    Am J Cardiol. 2016 Mar 19. pii: S0002-9149(16)30366.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: